Medpace Holdings, Inc. (BMV:MEDP)

Market Cap	213.18B +30.3%
Revenue (ttm)	48.28B +24.2%
Net Income	8.30B +10.6%
EPS	286.66 +21.5%
Shares Out	n/a
PE Ratio	25.69
Forward PE	24.36
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34
Average Volume	323
Open	7,022.03
Previous Close	5,880.00
Day's Range	7,022.03 - 7,022.03
52-Week Range	5,764.00 - 7,022.03
Beta	n/a
RSI	65.56
Earnings Date	Apr 22, 2026

About Medpace Holdings

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data man...

• Industry: Commercial Physical and Biological Research
• Founded: 1992
• Employees: 6,300
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: MEDP

Financial Performance

In 2025, Medpace Holdings's revenue was $2.53 billion, an increase of 19.97% compared to the previous year's $2.11 billion. Earnings were $451.12 million, an increase of 11.57%.

Financial numbers in USD